Immunological studies in patients with central nervous system tumors

L. Palmas, Viviana Moschese, Elena Galli, Concetta Barbieri, V. R M Lombardi, P. Rossi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Impairment of cell-mediated immunity in patients with primary central nervous system (CNS) tumors has repeatedly been reported but data to demonstrate the undelying immunological defect are not univocal. This report concerns a series of 31 patients harboring a glioma in which we studied: 1) peripheral blood Tlymphocyte subpopulations by monoclonal antibody analysis; 2) cellular responsiveness to mitogens 3) serum immunoglobulin values. The same parameters were also evaluated in 7 cases of intracranial meningioma and in 8 patients affected by non-proliferative, non-inflammatory CNS diseases. Thirty age-matched healthy volunteers formed the control group. Neither impairment of Tcells as regard to number, responsiveness and subsets, nor abnormal Ig values were found in these groups. However two patients, harboring respectively a third ventricle low grade astrocytoma and an anterior callosal glioblastoma, presented a striking Tcells impairment. These findings might suggest a correlation between hypothalamus and immune system, as already postulated by several previous experimental and clinical studies.

Original languageEnglish
Pages (from-to)29-35
Number of pages7
JournalJournal of Neuro-Oncology
Volume5
Issue number1
DOIs
Publication statusPublished - Mar 1987

Fingerprint

Central Nervous System Neoplasms
Third Ventricle
Corpus Callosum
Central Nervous System Diseases
Astrocytoma
Meningioma
Glioblastoma
Mitogens
Cellular Immunity
Glioma
Hypothalamus
Immunoglobulins
Immune System
Healthy Volunteers
Monoclonal Antibodies
Control Groups
Serum

Keywords

  • brain tumors
  • monoclonal antibodies
  • T-cell subsets

ASJC Scopus subject areas

  • Neuroscience(all)
  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Palmas, L., Moschese, V., Galli, E., Barbieri, C., Lombardi, V. R. M., & Rossi, P. (1987). Immunological studies in patients with central nervous system tumors. Journal of Neuro-Oncology, 5(1), 29-35. https://doi.org/10.1007/BF00162762

Immunological studies in patients with central nervous system tumors. / Palmas, L.; Moschese, Viviana; Galli, Elena; Barbieri, Concetta; Lombardi, V. R M; Rossi, P.

In: Journal of Neuro-Oncology, Vol. 5, No. 1, 03.1987, p. 29-35.

Research output: Contribution to journalArticle

Palmas, L, Moschese, V, Galli, E, Barbieri, C, Lombardi, VRM & Rossi, P 1987, 'Immunological studies in patients with central nervous system tumors', Journal of Neuro-Oncology, vol. 5, no. 1, pp. 29-35. https://doi.org/10.1007/BF00162762
Palmas, L. ; Moschese, Viviana ; Galli, Elena ; Barbieri, Concetta ; Lombardi, V. R M ; Rossi, P. / Immunological studies in patients with central nervous system tumors. In: Journal of Neuro-Oncology. 1987 ; Vol. 5, No. 1. pp. 29-35.
@article{c98d81d74e4c4a1a959322f7cdf70b6f,
title = "Immunological studies in patients with central nervous system tumors",
abstract = "Impairment of cell-mediated immunity in patients with primary central nervous system (CNS) tumors has repeatedly been reported but data to demonstrate the undelying immunological defect are not univocal. This report concerns a series of 31 patients harboring a glioma in which we studied: 1) peripheral blood Tlymphocyte subpopulations by monoclonal antibody analysis; 2) cellular responsiveness to mitogens 3) serum immunoglobulin values. The same parameters were also evaluated in 7 cases of intracranial meningioma and in 8 patients affected by non-proliferative, non-inflammatory CNS diseases. Thirty age-matched healthy volunteers formed the control group. Neither impairment of Tcells as regard to number, responsiveness and subsets, nor abnormal Ig values were found in these groups. However two patients, harboring respectively a third ventricle low grade astrocytoma and an anterior callosal glioblastoma, presented a striking Tcells impairment. These findings might suggest a correlation between hypothalamus and immune system, as already postulated by several previous experimental and clinical studies.",
keywords = "brain tumors, monoclonal antibodies, T-cell subsets",
author = "L. Palmas and Viviana Moschese and Elena Galli and Concetta Barbieri and Lombardi, {V. R M} and P. Rossi",
year = "1987",
month = "3",
doi = "10.1007/BF00162762",
language = "English",
volume = "5",
pages = "29--35",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Immunological studies in patients with central nervous system tumors

AU - Palmas, L.

AU - Moschese, Viviana

AU - Galli, Elena

AU - Barbieri, Concetta

AU - Lombardi, V. R M

AU - Rossi, P.

PY - 1987/3

Y1 - 1987/3

N2 - Impairment of cell-mediated immunity in patients with primary central nervous system (CNS) tumors has repeatedly been reported but data to demonstrate the undelying immunological defect are not univocal. This report concerns a series of 31 patients harboring a glioma in which we studied: 1) peripheral blood Tlymphocyte subpopulations by monoclonal antibody analysis; 2) cellular responsiveness to mitogens 3) serum immunoglobulin values. The same parameters were also evaluated in 7 cases of intracranial meningioma and in 8 patients affected by non-proliferative, non-inflammatory CNS diseases. Thirty age-matched healthy volunteers formed the control group. Neither impairment of Tcells as regard to number, responsiveness and subsets, nor abnormal Ig values were found in these groups. However two patients, harboring respectively a third ventricle low grade astrocytoma and an anterior callosal glioblastoma, presented a striking Tcells impairment. These findings might suggest a correlation between hypothalamus and immune system, as already postulated by several previous experimental and clinical studies.

AB - Impairment of cell-mediated immunity in patients with primary central nervous system (CNS) tumors has repeatedly been reported but data to demonstrate the undelying immunological defect are not univocal. This report concerns a series of 31 patients harboring a glioma in which we studied: 1) peripheral blood Tlymphocyte subpopulations by monoclonal antibody analysis; 2) cellular responsiveness to mitogens 3) serum immunoglobulin values. The same parameters were also evaluated in 7 cases of intracranial meningioma and in 8 patients affected by non-proliferative, non-inflammatory CNS diseases. Thirty age-matched healthy volunteers formed the control group. Neither impairment of Tcells as regard to number, responsiveness and subsets, nor abnormal Ig values were found in these groups. However two patients, harboring respectively a third ventricle low grade astrocytoma and an anterior callosal glioblastoma, presented a striking Tcells impairment. These findings might suggest a correlation between hypothalamus and immune system, as already postulated by several previous experimental and clinical studies.

KW - brain tumors

KW - monoclonal antibodies

KW - T-cell subsets

UR - http://www.scopus.com/inward/record.url?scp=0023183595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023183595&partnerID=8YFLogxK

U2 - 10.1007/BF00162762

DO - 10.1007/BF00162762

M3 - Article

VL - 5

SP - 29

EP - 35

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -